Kirin Holdings Co (KIR0) Stock Price & Analysis
KIR0 Stock Chart & Stats
- Day’s Range
- EUR 15.90 - EUR 15.90
- 52-Week Range
- EUR 11.90 - EUR 16.80
- Previous Close
- EUR 16.00
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 13.62B
- Enterprise Value
- EUR 20.02B
- Total Cash (Recent Filing)
- EUR 175.66B
- Total Debt (Recent Filing)
- EUR 843.60B
- Price to Earnings (P/E)
- 12.6
- Beta
- 0.23
- Next Earnings
- Nov 11, 2026 (Est.)
- EPS Estimate
- 0.24
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.37%
Bulls Say, Bears Say
Bulls Say
Improving Profitability And Margins
The substantial recovery in net and operating margins indicates stronger cost control and/or product mix. If maintained, improved profitability can support reinvestment, debt reduction and resilience across Kirin’s beverage and pharmaceutical businesses.
Improving Balance-sheet Leverage
Moderating leverage and a larger equity base improve financial flexibility for brand investment, product development and strategic growth. The healthier capital structure also reduces vulnerability to weaker demand or temporary earnings pressure.
Rebounding Free Cash Flow
The rebound in operating and free cash flow strengthens Kirin’s ability to fund dividends, capital spending, innovation and deleveraging internally. Sustained cash generation would support long-term investment across its diversified consumer and pharmaceutical operations.
Bears Say
Weak Cash Conversion
Despite positive cash generation, the limited conversion of accounting earnings into free cash flow points to working-capital swings and/or elevated reinvestment needs. Persistent weakness could constrain shareholder returns, debt reduction and growth spending.
Meaningful Residual Debt Exposure
Improving leverage is supportive, but sizeable debt still leaves Kirin exposed if profitability weakens. Higher obligations can limit flexibility for acquisitions, product investment and shareholder distributions, particularly during softer beverage demand.
Modest And Inconsistent Growth Profile
Revenue growth remains steady rather than strong, while prior margin deterioration shows that earnings momentum has not been fully consistent. Kirin may therefore need sustained innovation, pricing and mix improvement to accelerate durable growth.
Kirin Holdings Co News
Kirin’s LC-Plasma Trial Reaches Completion: What Investors Should Watch Next
Kirin Holdings Company, Limited ($KNBWY) announced an update on their ongoing clinical study. The clinical trial “A Randomized Controlled Trial Evaluating the Efficacy of Lactococcus Lactis JCM 5805 (LC-Plasma) Lactic
Kirin Holdings’ Citicoline Study: A Potential Game-Changer for Mood Enhancement?
Kirin Holdings Company, Limited (($KNBWY)) announced an update on their ongoing clinical study. Study Overview: Kirin Holdings Company, Limited is conducting a clinical trial titled ‘Exploring the Effects of Citicoline
KIR0 FAQ
What was Kirin Holdings Co’s price range in the past 12 months?
What is Kirin Holdings Co’s market cap?
When is Kirin Holdings Co’s upcoming earnings report date?
How were Kirin Holdings Co’s earnings last quarter?
Is Kirin Holdings Co overvalued?
Does Kirin Holdings Co pay dividends?
What is Kirin Holdings Co’s EPS estimate?
How many shares outstanding does Kirin Holdings Co have?
What happened to Kirin Holdings Co’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Kirin Holdings Co?
What is the TipRanks Smart Score and how is it calculated?
Kirin Holdings Co Stock Smart Score
Company Description
Kirin Holdings Co
Kirin Holdings Company, Limited, a diversified global conglomerate, was established in 1885 and maintains its headquarters in Tokyo, Japan. This entity operates across Japan and internationally, manufacturing and marketing a broad array of products. Its core activities are structured around four key divisions: Japan Beer and Spirits, Japan Non-Alcoholic Beverages, Oceania Integrated Beverages, and Pharmaceuticals. Kirin's extensive product portfolio encompasses alcoholic beverages such as beer (including happo-shu), wine, whiskey, and spirits, alongside soft drinks, dairy items, and fruit juices. Beyond beverages, the company is a developer and purveyor of pharmaceutical and biochemical goods. Its operations extend to managing various factories and theme parks, overseeing a chain of Kirin City beer pubs, and manufacturing specialized amino acids and nucleic acids for both pharmaceutical and industrial applications, including bulk pharmaceuticals. Additionally, Kirin crafts items such as margarine, jams, and honey. The company is also involved in the production and distribution of Coca-Cola products, other soft drinks, sake, and various food items. Furthermore, it manufactures and supplies Four Roses bourbon and functions as an insurance agency. Kirin Holdings underwent a name change in July 2007, having previously been recognized as Kirin Brewery Company, Limited.
- Sector
- Consumerdefensive
- Industry
- Beverages - Alcoholic
- CEO
- Yoshinori Isozaki
- Employees
- 31,144
- Website
- www.kirinholdings.com
- Address
- Nakano Central Park South, Tokyo, TY, 164-0001, JP
Kirin Holdings Co (KIR0) Earnings & Revenues
KIR0 Company Deck
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 5 | 1 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 12 | 0 | 0 |
